Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of BIBV 308 SE, Versus a Solution of BIBV 308 SE in Healthy Subjects
Clinical trial NCT02223013 · COMPLETED
Trial details
- NCT number
- NCT02223013
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-04-01
- Primary completion
- 1999-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.